SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending as community members rally around its anti-establishment narrative, viewing it as a movement against traditional retirement systems. Buoyed by a strong and active community, the coin's mission is to challenge the status quo. Discussions revolve around its potential for significant growth and staking opportunities.

Alchemy Pay

ACH is trending with community members discussing its potential and expressing frustration over its price action. Some point to upcoming catalysts like new partnerships and the potential launch of Alchemy Chain. Others speculate on buyout or merger possibilities, while many are focused on short-term price movements and potential gains.

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

eXoZymes Inc.

eXoZymes ($EXOZ) is trending due to its advancements in cell-free biomanufacturing, particularly the 100-fold scale-up of NCT production with impressive efficiency. The community is focused on the potential of NCT in the nutraceutical and pharmaceutical markets, especially its role alongside GLP-1 drugs and in addressing liver health. Discussions also highlight the company's AI-driven approach and partnerships, positioning eXoZymes as a leader in sustainable biomanufacturing.

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

Orca ($ORCA) is trending due to an explosive price surge following a $36M Upbit exchange hack, which triggered a short squeeze as traders aggressively shorted the token. Community members are actively discussing entry points and potential short-term gains, while also pointing to the project's ecosystem growth and accessibility improvements as bullish catalysts. Recent ecosystem developments like MetaMask integration and potential buybacks may be contributing to positive sentiment.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community anticipates a breakout, referencing bullish chart patterns and a potential surge towards $110. Discussions include long-term potential, historical price comparisons, and its role as 'digital silver' in the crypto market, while some traders express frustration with recent price action and volatility.

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Ligand Pharmaceuticals ($LGND) is trending due to recent analyst target price raises and positive ratings, highlighting an improved growth outlook. Community discussion points to potential pipeline valuation debates and upcoming catalysts, including key PDUFA dates and trial data releases. The stock's royalty-based business model and diversified biopharma strategy are also attracting attention.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

DESTINY TECH 100 INC is trending due to speculation surrounding a potential SpaceX IPO and DXYZ's significant holdings in the company, driving investor interest. The community is actively debating the fund's valuation relative to its net asset value and comparing it to other SpaceX investment options like EchoStar. Discussions also include DXYZ's other private tech holdings, such as OpenAI, and their potential impact on the stock's price.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending due to news around stablecoins and blockchain, with community members weighing the potential disruption to traditional payment networks. Some analysts highlight the company's proactive approach and investments in these areas, while others suggest the stock may be oversold. Bullish community members see any dip as a buying opportunity, citing Mastercard's strong fundamentals and historical performance.

Sui is an innovative layer-1 blockchain platform crafted to meet the demands of global adoption, providing a secure, robust, and scalable development environment. Rooted in a unique object-centric data model and fortified by the trusted Move programming language, Sui is engineered to tackle the inefficiencies found in current blockchain frameworks.  In addition to its solid technical underpinnings, Sui places a strong emphasis on user experience, aiming to remove common barriers encountered in blockchain interactions. Through groundbreaking features such as zkLogin, sponsored transactions, and programmable transaction blocks, Sui sets a new standard for user accessibility and friendliness within Web3 applications.  Unique elements of Sui Sui’s innovative architecture ensures swift transactions with stable fees and high throughput through horizontal scaling. Its object-oriented design offers deep composability for developers, enabling tailored object types with network-wide compatibility. This revolutionizes asset and protocol collaboration, fostering product innovation.  The platform's object-oriented approach dramatically improves transaction processing, enabling parallel execution and faster completion times. Additionally, unique consensus requirements expedite transaction finalization while maintaining stability. Sui prioritizes overcoming Web3 adoption barriers, offering native tools like zkLogin and sponsored transactions for wallet onboarding and fee management.  Move integration into Sui's data model combines innovation with security, mitigating common exploits found in smart contract languages. This empowers developers and users with a secure and intuitive platform, accelerating the evolution of Web3 applications.  About the Sui token The SUI token serves four primary functions within the Sui ecosystem: Proof-of-stake participation - Sui implements a delegated proof-of-stake mechanism, rewarding honest behavior by validators and SUI token holders who stake with them. Gas fee payments - SUI tokens cover gas fees for executing transactions and storing data onchain. Application utility - SUI is a versatile asset, integral to various applications within Sui’s ecosystem, including decentralized exchanges, lending platforms, gaming, and more. Governance - The SUI token empowers holders to participate in on-chain voting on significant matters like protocol upgrades and platform changes, shaping the future of Sui.  Additionally, the Sui storage fund ensures fair compensation for validators by distributing stake rewards over time and covering storage costs for previously stored on-chain data. This tokenomic strategy promotes indefinite data storage while maintaining fair compensation for validators, fostering long-term sustainability.

SUI is trending as the community discusses its potential for institutional adoption and its underlying technology, including the Move language. Comparisons are being drawn to other Layer 1 solutions like Keeta, with community members debating the merits of each. Catalysts mentioned include potential ETF approvals and increased transaction volume.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending as investors discuss the potential approval of Anaphylm, a needle-free epinephrine film, with the PDUFA date approaching at the end of January. Community talking points revolve around comparing Anaphylm to existing treatments like EpiPen and Neffy, as well as speculating on the likelihood of approval and potential buyout scenarios. Some investors are closely monitoring short interest and recent institutional activity for signals about the FDA's decision.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eastman Chemical Boosts Dividend Leveraging Strong Cash Generation  

EMN lifts its dividend again as strong cash flow, cost cuts and inventory actions position the company for a gradual recovery ahead. 

POSCO Secures Control of Sampoerna Agro in KRW 1.3T Deal 

POSCO expands its palm oil empire with a major acquisition and new refinery, creating a fully integrated value chain from seeds to biofuel feedstock. 

Glencore (GLNCY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After losing some value lately, a hammer chart pattern has been formed for Glencore (GLNCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Is Glencore (GLNCY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Glencore (GLNCY) a Great Value Stock Right Now?

Should Value Investors Buy Glencore (GLNCY) Stock?

Perpetua Resources (PPTA) is reportedly in talks with Glencore, Trafigura, and other parties about a partnership to refine antimony in the U.S., amid widespread efforts to diversify the supply chains of the critical mineral.According to a Reuters News <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/china/perpetua-resources-talks-with-glencore-others-us-antimony-processing-2025-09-26/">report</a>, the company confirmed that it is speaking with two companies, alongside Clarios and Sunshine Silver, about a refining partnership and intends to request proposals in the coming weeks, with a decision expected by the end of the year.Antimony has a wide range of applications, including night vision technology, explosives, armor-piercing ammunition, and grid-scale energy storage batteries. Perpetua’s Stibnite project holds the biggest reserve of antimony in the U.S. The company began construction at the mine last week, having secured all the necessary permits."We are encouraged by emerging opportunities to expand domestic mineral processing capacity in America and intend to make well-informed, market-based decisions when selecting a partner," Jon Cherry, Perpetua's CEO, reportedly stated.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/PPTA">Perpetua</a> was in the ‘extremely bullish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:794/92;" src="https://news.stocktwits-cdn.com/PPTA_Sept_26_JPG_b19bc70dbe.webp" alt="PPTA’s Sentiment Meter and Message Volume as of 11:52 p.m. ET on Sept. 25, 2025 | Source: Stocktwits" width="794" height="92"><figcaption>PPTA’s Sentiment Meter and Message Volume as of 11:52 p.m. ET on Sept. 25, 2025 | Source: Stocktwits</figcaption></figure>The Trump administration is seeking to bolster the domestic mining industry in an effort to reduce its reliance on China, which accounted for over 80% of U.S. antimony exports. Earlier this week, another refiner, United States Antimony, got a contract worth up to $245 million from the U.S. Defense Logistics Agency to supply antimony metal ingots.Once operational, the Pentagon-backed Stibnite project could supply 35% of the anticipated U.S. antimony demand, according to the United States Geological Survey 2025. The project also holds 4.8 million ounces of gold, which will be another source of earnings for the company.Perpetua stock has nearly gained 76% this year, compared with a 60% rise of the SPDR Metals &amp; Mining ETF (XME).Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-lightpath-technologies-stock-fall-after-hours-today/chDVbmyR3IP">Why Did Lightpath Technologies' Stock Fall After-Hours Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the logo of Glencore is displayed on the screen of a tablet. 

Perpetua Resources Speaking With Glencore, Trafigura To Bolster US Antimony Refining Amid China Export Ban: Report 

Perpetua’s Stibnite project holds the biggest reserve of antimony in the U.S. The company began construction at the mine last week, having secured all the necessary permits.

Equity

Chevron Reshapes Portfolio With Singapore Refinery Stake Exit

CVX plans to exit its Singapore refinery stake, with Vitol and Glencore emerging as top contenders in a $1 billion deal reshaping Asia's energy trade.

Swiss commodities trader Glencore said on Wednesday that it intends to maintain its primary listing in London, following earlier consideration of relocating to New York this year.According to a report by the Financial Times, Glencore CEO Gary Nagle said on Wednesday that the company was skeptical about whether a move would deliver value to shareholders, as it was unlikely to have been included in the S&amp;P 500 if it had shifted to New York.“We don’t believe there is a value-accretive proposition to move exchanges right now,” Nagle said, after saying that the company had conducted a review of exchanges and found New York to be the most suitable candidate for a move.Apart from the S&amp;P inclusion, described as a “big factor” behind Nagle's decision, the company also considered the significant costs associated with a change, as per the <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/9d252c78-a03d-439b-806e-7f78fef8b299">report</a>.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/GLNCY">Glencore</a> was in the ‘bearish’ territory at the time of writing.Glencore’s decision came as a relief for the London bourse, which has seen the departure of several high-profile companies, including chipmaker Arm and building materials supplier CRH, over the past few years.According to a Bloomberg News report, London has lost 25% of its companies over the past decade following uncertainty over post-Brexit Britain and some calamitous policy moves that eroded investor confidence in the UK economy. Shell, the biggest company in the FTSE 100 index, has also explored a move away from London.Separately, Glencore reported a 14% drop in first-half profit to $5.43 billion. Its copper production slipped 26% compared to the same period last year due to lower ore grades at several mines. The company plans to reduce costs by $1 billion by the end of the year.Glencore U.S. shares have declined by over 10% this year amid a drop in coal price.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/uber-s-robotaxi-growth-in-focus-ahead-of-q2-earnings/chr1r9ERdPF">Uber’s Robotaxi Growth In Focus Ahead Of Q2 Earnings — Analyst Says Tesla Will Not Be The Undisputed Leader</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Glencore Scraps New York Listing Plan Over S&P 500 Inclusion Doubts, Will Stick With London: ‘Don’t Believe There Is A Value-Accretive Proposition’

The company also considered the significant costs behind a change in bourses. 

Glencore Scraps New York Listing Plan Over S&P 500 Inclusion Doubts, Will Stick With London

J.P. Morgan resumes Glencore coverage with “overweight,” £3.60 price target

Glencore Plc engages in the production and marketing of metal, mineral, and energy and agricultural commodities. The firm serves the automotive, steel, power generation, battery manufacturing, and oil sectors. It operates through the following segments: Marketing, Industrial, and Corporate and Other. The Marketing segment includes net sale and purchase of physical commodities, and provision of marketing and related value-add services. The Industrial segment deals with the sale of physical commodities over the cost of production and/or cost of sales. The Corporate and Other segment represents group related income and expenses. The company was founded in 1974 and is headquartered in Baar, Switzerland.

Current Price	$10.02
Prev Close	$10.23
Open	$10.18
Dividend Yield	1.95%
50-Day Moving Average	$9.46
Beta	1.01
Avg. Volume	481,913.42
PE Ratio	-29.40

52-Week High	$10.28
52-Week Low	$5.74
Market Capitalization	$58.76B
EPS (Annual)	-$0.2688
Price to Book	1.58
Revenue Per Employee	$1.54M
Enterprise Value/EBITDA	N/A

GLNCY
Glencore Unsp ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLNCY News

GLNCYGlencore Unsp ADR